Drug Pipeline

Xiidra (Lifitegrast ophthalmic solution) 5% Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 4
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07560735 Clinical Evaluation of Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease Using In… Dry Eye Not Yet Recruiting
NCT07025811 A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants… Dry Eye Disease Active, Not Recruiting
Not specified
NCT04354545 Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications Glaucoma Recruiting
Sponsors Running Xiidra (Lifitegrast ophthalmic solution) 5% Trials
University of California, Los Angeles (1) Hoffmann-La Roche (1) Toyos Clinic (1)
Get alerts when Xiidra (Lifitegrast ophthalmic solution) 5% trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free